Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lens intrinsic membrane protein 2 (LIM2) is an abundant eye lens-specific integral membrane protein found primarily at the junctions of lens fiber cells, where it contributes to organization and communication between cells[5][8]. LIM2 contains four transmembrane domains, is a substrate for cAMP-dependent protein kinase and protein kinase C, and is capable of binding calmodulin[1][2]. It is the second most abundant intrinsic membrane protein in lens fiber cells after aquaporin-0 and plays a significant role in maintaining lens transparency and normal lens homeostasis[3][4]. Genetic mutations in the LIM2 gene have been linked to inherited cataracts, highlighting its importance in lens development and disease[3][4]. There are no drugs known to target LIM2, and it is not currently considered a therapeutic target, but it plays a crucial structural and physiological role in the eye lens[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lens intrinsic membrane protein 2 (LIM2).